Rx Importation Would Require Increased Wholesaler Regulation, PhRMA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
PhRMA Assistant General Counsel Lassman says a commercial drug importation program would be unsafe until wholesalers are “adequately” regulated. Certain states are strengthening wholesaler regulation, but the problem is “not solved by any means right now,” Lassman says.